🆕 ACC Scientific Statement: Exercise is a foundational component of #CVD prevention & treatment. The biggest drop in CV risk happens when sedentary people become more active. Exercise prescriptions should be safe, personalized, achievable, & sustainable. bit.ly/4hxfedX

In this #JACCINT meta-analysis of 4 RCTs (n=2,651 #STEMI + multivessel disease), immediate complete revascularization was associated w/ ⬆️ 1-year all-cause mortality vs staged (HR 1.50)—but reduced MI (HR 0.58). bit.ly/4B9eKm9

In 4,398 pts w/out diagnostic ST elevation, the OMI/NOMI approach selected more pts for early invasive management vs conventional very-high-risk #NSTEMI criteria (45.4% vs 13.6%) and identified acute coronary occlusion sooner (35.1% vs 16.7%). #JACCINT bit.ly/3VTiqbl

#JACCIMG meta-analysis: Sex matters in valvular heart disease. At the time of primary mitral regurgitation intervention, women are older, have more symptoms, more tricuspid regurgitation, and worse long-term outcomes compared with men. bit.ly/3Uy5GGK #vhdMR #cvVHD

Could patient-administered subcutaneous furosemide help pts w/ HF get home sooner? In SUBCUT-HF II, early-discharge strategy using subq furosemide added 4 days alive & out of hospital at 1 month & shortened index stay by 5.5 days comp. to usual care. bit.ly/4hWJb6d #JACC

The 2026 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction is here! What’s new in #HFpEF management? Read here: bit.ly/4hu2fdb #JACC #CardioX

In the prospective, real-world PROSPECT MONSTER study, second-generation low-dose DCB demonstrated 3-year clinical outcomes comparable to first-generation high-dose DCB in pts w/ complex femoropopliteal artery disease. #JACCCEP #cvPAD bit.ly/4zGUTt0

With the 37th #GWICC/AHS 2026 meeting taking place in Beijing, explore a recent #JACC focus issue highlighting some of the best cardiovascular science from China: bit.ly/3WdCKnU

A randomized double-blind trial in pts with suboptimally controlled hyperlipidemia showed: ➡️Quarterly SHR-1918 (ANGPTL3 antibody) significantly ⬇️ LDL-C (~21–25%) and triglycerides (~50–59%) at 24 weeks. #JACCAsia #Lipids #cvPrev bit.ly/4hOJqkX

Potassium binders lower potassium in #HeartFailure w/ reduced ejection fraction, but 4 trials show inconsistent support for mineralocorticoid receptor antagonist use & no proven benefit on death/hospitalization. Hypokalemia remains a safety signal. bit.ly/4illp52 #JACC

Should you screen your patient with #Diabetes for #HeartFailure? New in #JACC: The TARTAN-HF trial Read more in the newest issue: bit.ly/3VNf0qC

⚡ In #CardiogenicShock pts supported by PVAD, the trajectory of RV #Hemodynamics may matter as much as the initial measurement. Serial right-heart hemodynamics may help identify pts who need earlier escalation of RV-directed support. #JACCAdvances bit.ly/47t30gz

In 6,558 #ACS pts from MATRIX trial, angiographically-defined #OMI identified pts w/ >1-year mortality—while adding troponin peak values ⬆️ OMI frequency but diluted prognostic effects. NSTE-ACS pts mtg OMI criteria had STEMI-equiv. mortality. #JACCINT bit.ly/4jpROZq

#JACC Editor-in-Chief @hmkyale & #JACCCardioOnc Editor-in-Chief @DrBonnieKy are at #GWICC/AHS 2026, taking part in a joint #JACCJournals LBCT Session & an Editors' Forum w/ @TheLancet. See all JACC events & simultaneous publications from the meeting at: bit.ly/4inVxFD

We know how to identify who is at CV risk. But do we know where prevention is most needed? A new #JACC Editorial Comment looks at how occupational context can help uncover gaps in treatment, control and prevention. Read more: bit.ly/4zXtL9h #GWICC #cvPrev

Pediatric & adolescent arrhythmogenic #cardiomyopathy carries a high burden of malignant VAs & end-stage HF. #whyCMR RVGLS provides incremental prognostic value beyond conventional parameters & improves risk stratification. #JACCIMG @Dr_Zhao_Shihua bit.ly/4ynQQR6

Aerobic exercise is well tolerated & improves CRF in long-term anthracycline-treated BCS more than a decade after treatment. However, the exercise response was attenuated compared with non-cancer subjects. jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc #BreastCancerAwareness #BCsm

Can where people work reveal where #CVD prevention is most needed? New research presented at #GWICC/AHS 2026 & published in #JACC examines CV risk, treatment and control across China’s workforce, highlighting opportunities for #cvPrev. Read more: bit.ly/4yX16kq

Using machine learning on multi-omics data from pts w/ dilated cardiomyopathy, Chen et al. identify TARS2 as a novel regulator of mitochondrial dysfunction & pathological remodeling in DCM. Find out what TARS2 does in this month’s #JACCBTS! #HFrEF bit.ly/4zzAzts

A case in #JACCCaseReports shows that #CMR is mandatory in suspected eosinophilic myocarditis when echocardiography is negative. In steroid-refractory hypereosinophilic syndrome, early interleukin-5 inhibition is a life-saving intervention. #cvImaging bit.ly/4jXZKRB